Funding for this research was provided by:
National Natural Science Foundation of China (81972562, 81972566)
Beijing Natural Science Foundation (7214217)
Beijing Hospitals Authority Youth Programme (QMS20211101)
Article History
Accepted: 8 December 2021
First Online: 5 May 2022
Declarations
:
: All authors have made a substantial contribution to the material submitted for publication and have read and approved the manuscript.
: Dr. Jun Guo serves as consultant or is on advisory boards for MSD, Roche, Pfizer, Bayer, Novartis, Simcere Pharmaceutical Group, Shanghai Junshi Biosciences, and Oriengene. Dr. Xue Bai has received a merit award supported by BMS. Dr. Lu Si has received speakers’ honoraria from MSD, Roche, Novartis, Shanghai Junshi Biosciences, and Oriengene.